Litfulo (ritlecitinib): Uppdaterade rekommendationer för att minimera risken för allvarliga biverkningar
Information till hälso- och sjukvården – DHPC.
Read the original at the source: https://www.lakemedelsverket.se/link/f139b093b5ac454db506fb2d922a7169.aspx
Officially imported this from Läkemedelsverket’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Läkemedelsverket — imported from official source
- Official source
- https://www.lakemedelsverket.se/api/newslist/newsrss?query=&pageTypeId=&from=&to= ATOM
- Imported
- October 03, 2026 20:38
- Versions
- 1 recorded
- Identity
urn:uuid:f139b093-b5ac-454d-b506-fb2d922a7169